| 发明名称 |
IMMUNOGENIC COMPOSITION |
| 摘要 |
The invention provides an immunogenic composition comprising: a) a conjugate that is a capsular saccharide from GBS serotype Ia conjugated to a carrier protein; b) a conjugate that is a capsular saccharide from GBS serotype Ib conjugated to a carrier protein; c) a conjugate that is a capsular saccharide from GBS serotype III conjugated to a carrier protein; d) a conjugate that is a capsular saccharide from GBS serotype II conjugated to a carrier protein; and e) a conjugate that is a capsular saccharide from GBS serotype V conjugated to a carrier protein. |
| 申请公布号 |
US2015224204(A1) |
申请公布日期 |
2015.08.13 |
| 申请号 |
US201314424370 |
申请日期 |
2013.10.03 |
| 申请人 |
NOVARTIS AG |
发明人 |
Grandi Guido;Margarit Y Ros Immaculada;Maione Domenico |
| 分类号 |
A61K47/48;A61K9/00;A61K39/09 |
主分类号 |
A61K47/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An immunogenic composition comprising: a) a conjugate that is a capsular saccharide from GBS serotype Ia conjugated to a carrier protein; b) a conjugate that is a capsular saccharide from GBS serotype Ib conjugated to a carrier protein; c) a conjugate that is a capsular saccharide from GBS serotype III conjugated to a carrier protein; d) a conjugate that is a capsular saccharide from GBS serotype II conjugated to a carrier protein; and e) a conjugate that is a capsular saccharide from GBS serotype V conjugated to a carrier protein. |
| 地址 |
Basel CH |
